全文获取类型
收费全文 | 2622篇 |
免费 | 229篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 105篇 |
妇产科学 | 40篇 |
基础医学 | 311篇 |
口腔科学 | 85篇 |
临床医学 | 254篇 |
内科学 | 561篇 |
皮肤病学 | 31篇 |
神经病学 | 225篇 |
特种医学 | 147篇 |
外科学 | 275篇 |
综合类 | 188篇 |
一般理论 | 3篇 |
预防医学 | 160篇 |
眼科学 | 53篇 |
药学 | 276篇 |
3篇 | |
中国医学 | 10篇 |
肿瘤学 | 173篇 |
出版年
2022年 | 41篇 |
2021年 | 70篇 |
2020年 | 38篇 |
2019年 | 66篇 |
2018年 | 69篇 |
2017年 | 31篇 |
2016年 | 49篇 |
2015年 | 65篇 |
2014年 | 88篇 |
2013年 | 109篇 |
2012年 | 138篇 |
2011年 | 126篇 |
2010年 | 70篇 |
2009年 | 65篇 |
2008年 | 100篇 |
2007年 | 185篇 |
2006年 | 113篇 |
2005年 | 107篇 |
2004年 | 100篇 |
2003年 | 79篇 |
2002年 | 73篇 |
2001年 | 70篇 |
2000年 | 70篇 |
1999年 | 54篇 |
1998年 | 36篇 |
1997年 | 43篇 |
1996年 | 43篇 |
1995年 | 35篇 |
1994年 | 29篇 |
1993年 | 28篇 |
1992年 | 52篇 |
1991年 | 39篇 |
1990年 | 36篇 |
1989年 | 48篇 |
1988年 | 44篇 |
1987年 | 28篇 |
1986年 | 27篇 |
1985年 | 36篇 |
1984年 | 25篇 |
1983年 | 27篇 |
1982年 | 25篇 |
1981年 | 26篇 |
1980年 | 25篇 |
1979年 | 32篇 |
1978年 | 26篇 |
1977年 | 33篇 |
1976年 | 24篇 |
1975年 | 24篇 |
1973年 | 32篇 |
1971年 | 22篇 |
排序方式: 共有2930条查询结果,搜索用时 15 毫秒
51.
N M Lee H J Friedman L Leybin T M Cho H H Loh C H Li 《Proceedings of the National Academy of Sciences of the United States of America》1980,77(9):5525-5526
The synthetic beta-endorphin analogs with the omission of the NH2-terminal [Met]enkephalin segment [beta-endorphin-(6-31) and beta-endorphin-(20-31)] are shown to inhibit morphine- or beta-endorphin-induced analgesia in mice by the tail-flick test, whereas the synthetic NH2-terminal pentadecapeptide beta-endorphin-(1-15) has no inhibitory activity. This study raises the possibility that endogenous inhibiting peptides exist in the brain which play a role in the regulation of endorphin actions. 相似文献
52.
Michelle Loh Anju Bhatia Kai Lit Tan Edwin Thia George Seow Heong Yeo 《Singapore medical journal》2020,61(10):523
INTRODUCTIONFetoscopic laser photocoagulation (FLP), a treatment option for twin-to-twin transfusion syndrome (TTTS) in monochorionic twin pregnancies, is currently the treatment of choice at our centre. We previously reported on our experience of FLP from June 2011 to March 2014. This paper audits our fetal surgery performance since then.METHODS15 consecutive patients who underwent FLP for Stage II–III TTTS before 26 weeks of gestation from June 2011 to January 2017 were retrospectively reviewed, consisting of five cases from our initial experience and ten subsequent cases. Perioperative, perinatal and neonatal outcomes were analysed.RESULTSOf 15 pregnancies, 10 (66.7%) and 5 (33.3%) were for Stage II and III TTTS respectively, with FLP performed at an earlier Quintero stage in the later cohort. Overall mean gestational ages at presentation, laser and delivery were comparable between the cohorts at 19.7 (15.4–24.3) weeks, 20.3 (16.3–25.0) weeks and 31.2 (27.6–37.0) weeks, respectively. 2 (13.3%) cases had intra-amniotic bleeding and 1 (6.7%) had iatrogenic septostomy. 1 (6.7%) case had persistent TTTS requiring repeat FLP, and another (6.7%) had preterm premature rupture of membranes at seven weeks post procedure. The overall perinatal survival rate was 21 (75.0%) out of 28 infants. One mother underwent termination of pregnancy for social reasons at 1.4 weeks post procedure. Double survival occurred in 8 (57.1%) out of 14 pregnancies, while 13 (92.9%) had at least one survivor.CONCLUSIONFLP requires a highly specialised team and tertiary neonatal facility. Continual training improves maternal and perinatal outcomes, ensuring comparable standards with international centres. 相似文献
53.
S. Sabesan D. Allen P. Caldwell P. K. Loh R. Mozer P. A. Komesaroff P. Talman M. Williams N. Shaheen O. Grabinski The Royal Australasian College of Physicians Telehealth Working Group 《Internal medicine journal》2014,44(1):101-103
The fourth in a series of articles about the practical aspects of telehealth, this paper provides advice and information for specialists to communicate effectively with patients during a telehealth video consultation. 相似文献
54.
55.
56.
57.
58.
A previously healthy 20‐year‐old man presented with adult Still disease (ASD). He developed life‐threatening macrophage activation syndrome (MAS), which was refractory to standard immunosuppression but responded dramatically to the IL‐1 receptor antagonist anakinra. Subsequent immunological investigations included assessment of the perforin expression of natural killer (NK) cells and CD8+ T cells, which confirmed MAS. 相似文献
59.
Swati Mehta Katherine Orenczuk Amanda McIntyre Gabrielle Willems Dalton L. Wolfe Jane T. C. Hsieh Christine Short Eldon Loh Robert W. Teasell SCIRE Research Team 《Topics in spinal cord injury rehabilitation》2013,19(1):78-86
Background:
Pharmacotherapy may not sufficiently reduce neuropathic pain in many individuals post spinal cord injury (SCI). The use of alternative therapies such as surgery may be effective in reducing neuropathic pain in these individuals. However, because of the invasive nature of surgery, it is important to examine the evidence for use of this treatment.Objective:
The purpose of this study was to conduct a systematic review of published literature on the surgical treatment of neuropathic pain after SCI.Methods:
MEDLINE, CINAHL, EMBASE, and PsycINFO databases were searched for articles in which surgical treatment of pain after SCI was examined. Articles were restricted to the English language. Article selection was conducted by 2 independent reviewers with the following inclusion criteria: the subjects participated in a surgical intervention for neuropathic pain; at least 50% of the subjects had an SCI; at least 3 subjects had an SCI; and a definable intervention involving the dorsal root entry zone (DREZ) procedure was used to reduce pain. Data extracted included study design, study type, subject demographics, inclusion and exclusion criteria, sample size, outcome measures, and study results. Randomized controlled trials (RCTs) were assessed for quality using the Physiotherapy Evidence Database (PEDro) assessment scale. Levels of evidence were assigned to each intervention using a modified Sackett scale.Results:
Eleven studies met the inclusion criteria. One study provided level 2 evidence, and the rest provided level 4 evidence. The DREZ procedure was shown to be more effective for segmental pain than for diffuse pain after SCI. Further, individuals with conus medullaris level injury were found to have a higher level of neuropathic pain relief than those with cervical, thoracic, or cauda equina injury.Conclusions:
The studies demonstrated that the DREZ procedure may be effective in reducing segmental pain. Hence, DREZ may be important in treatment of neuropathic pain in individuals resistant to less invasive treatments. Because the studies lacked control conditions and examination of long-term effects, there is a need for larger trials with more stringent conditions.Key words: pain, spinal cord injury, surgical treatmentPain is a major cause of distress and disability in persons with spinal cord injury (SCI). It has been shown to lead to social isolation, unemployment, decreased function, decreased quality of life, depression, and even suicide.1,2 More than 77% of individuals with an SCI indicated that pain interfered with one or more of their daily activities including sleep (40%), exercise (34.9%), and work (33.6%).2 The International Association for the Study of Pain (IASP) defines neuropathic pain as “pain caused by a lesion or disease of the somatosensory nervous system.”3 After an SCI, individuals often report the onset of chronic neuropathic pain caudal to the level of the lesion or at the same level within the associated spinal cord segment.4 Dijkers et al5 reported no difference in the prevalence of pain based on level or completeness.The reported incidence of neuropathic pain after SCI varies greatly among studies, but between 10% and 30% of patients with SCI experience pain severe enough to interfere with their activities of daily living6,7 and may require surgical intervention to relieve persistent and refractory pain.4,8 Unmanageable neuropathic pain occurs more often in individuals with conus medullaris and cauda equina lesions where damage also involves the peripheral nerve roots.8When pharmacological and other noninvasive treatments fail to reduce pain, surgical spinal cord stimulation and dorsal root entry zone (DREZ) ablation treatments, such as DREZ lesioning and microsurgical DREZotomy (MDT), can be considered as options for the management of refractory pain.9 Neurosurgical procedures to reduce neuropathic pain should be reserved for cases in which medical therapies have failed to sufficiently reduce pain.4 The risks associated with ablative surgeries can be significant for individuals with incomplete neurological deficits; therefore, DREZ ablation is generally only considered a treatment option when neuropathic pain is present after a complete SCI.8 The MDT procedure targets for ablation the nociceptive fibers in the lateral bundle of the dorsal rootlet, the deafferented neurons of the dorsal horn, and the medial portion of the Lissauer tract.4,6 This systematic review was conducted to assess the effectiveness of DREZ ablation therapies in reducing neuropathic pain in individuals following SCI. 相似文献60.